tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

OBIO Stock Latest News

Orchestra BioMed reports Q2 EPS (50c), consensus (51c)
The FlyOrchestra BioMed reports Q2 EPS (50c), consensus (51c)
2d ago
OBIO
Orchestra BioMed announces rollout of FDA-approved BACKSEAT study update
PremiumThe Fly
Orchestra BioMed announces rollout of FDA-approved BACKSEAT study update
6d ago
OBIO
Orchestra BioMed secures over $111M in proceeds, committed capital
PremiumThe Fly
Orchestra BioMed secures over $111M in proceeds, committed capital
9d ago
MDT
LGND
Orchestra BioMed Holdings Closes $40M Public Offering
PremiumCompany Announcements
Orchestra BioMed Holdings Closes $40M Public Offering
9d ago
8K
OBIO
Orchestra BioMed prices 9.4M shares at $2.75 in underwritten public offering
PremiumThe Fly
Orchestra BioMed prices 9.4M shares at $2.75 in underwritten public offering
13d ago
OBIO
Strategic Partnerships and Financial Maneuvers Position Orchestra BioMed for Growth: A Buy Rating Justification
PremiumRatingsStrategic Partnerships and Financial Maneuvers Position Orchestra BioMed for Growth: A Buy Rating Justification
13d ago
OBIO
Orchestra BioMed Secures $70M for Cardiology Programs
Premium
Company Announcements
Orchestra BioMed Secures $70M for Cardiology Programs
13d ago
8K
OBIO
Orchestra BioMed announces common stock offering, no amount given
Premium
The Fly
Orchestra BioMed announces common stock offering, no amount given
13d ago
OBIO
Nine new option listings on July 30th
PremiumThe Fly
Nine new option listings on July 30th
15d ago
DOMH
OBIO
Orchestra BioMed Confirms Director Elections and Auditor
PremiumCompany Announcements
Orchestra BioMed Confirms Director Elections and Auditor
2M ago
8K
OBIO
Orchestra Biomed Reports Increased Losses Amid Revenue Growth
PremiumCompany Announcements
Orchestra Biomed Reports Increased Losses Amid Revenue Growth
2M ago
OBIO
Promising Innovations and Strategic Advancements Drive Buy Rating for Orchestra BioMed Holdings
PremiumRatings
Promising Innovations and Strategic Advancements Drive Buy Rating for Orchestra BioMed Holdings
3M ago
OBIO
Orchestra BioMed reports Q1 EPS (49c), consensus (48c)
PremiumThe FlyOrchestra BioMed reports Q1 EPS (49c), consensus (48c)
3M ago
OBIO
Orchestra BioMed announces continued expansion of global property estate
Premium
The Fly
Orchestra BioMed announces continued expansion of global property estate
3M ago
OBIO
Orchestra BioMed price target lowered to $12 from $16 at Barclays
Premium
The Fly
Orchestra BioMed price target lowered to $12 from $16 at Barclays
3M ago
OBIO
Orchestra BioMed Receives FDA Approval for IDE Amendment
PremiumCompany Announcements
Orchestra BioMed Receives FDA Approval for IDE Amendment
4M ago
8K
OBIO
Orchestra BioMed receives approval of IDE to initiate Virtue Trial
PremiumThe Fly
Orchestra BioMed receives approval of IDE to initiate Virtue Trial
4M ago
OBIO
Orchestra BioMed Holdings: Buy Rating Affirmed on Breakthrough Device Designation and Promising AVIM Therapy Developments
PremiumRatings
Orchestra BioMed Holdings: Buy Rating Affirmed on Breakthrough Device Designation and Promising AVIM Therapy Developments
4M ago
OBIO
Orchestra BioMed granted breakthrough device designation, says H.C. Wainwright
PremiumThe Fly
Orchestra BioMed granted breakthrough device designation, says H.C. Wainwright
4M ago
OBIO
Orchestra BioMed announces AVIM therapy-focused satellite symposium at HRS 2025
PremiumThe FlyOrchestra BioMed announces AVIM therapy-focused satellite symposium at HRS 2025
4M ago
OBIO
Orchestra BioMed receives FDA BDD for AVIM therapy
Premium
The Fly
Orchestra BioMed receives FDA BDD for AVIM therapy
4M ago
OBIO
Orchestra BioMed’s Strategic Advances in Medical Innovations
Premium
Company Announcements
Orchestra BioMed’s Strategic Advances in Medical Innovations
4M ago
OBIO

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >